Intrinsiqs

Is 4D Molecular Therapeutics, Inc. overvalued?

4D Molecular Therapeutics, Inc. (FDMT) — key valuation metrics and fundamentals.

No verdict
Price
$12.19
Fair value
Current P/E
Normal P/E
Market cap
$637.2M
Dividend yield
0.0%
Return on equity
-36.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares FDMT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.